SAM, Linklaters, JSA Act On Biocon’s $460 Million QIP Biopharamaceuticals January 19, 2026 Capital Markets
JSA, Trilegal Advised On Travelstack Tech’s Proposed IPO Travel Tech December 26, 2025 Capital Markets – Equity
JSA Advised Syrma SGS Technology On Its ₹1000 Cr QIP Electronics Manufacturing August 20, 2025 Capital Markets – Equity
JSA Advised Biocon Limited In Raising ₹4500 Cr Through A QIP Biopharamaceuticals June 27, 2025 Capital Markets – Equity
JSA Advised BRLMs On Prozeal Green Energy’s Proposed IPO Renewable Energy April 8, 2025 Capital Markets – Equity
SNG & Partners represents UGRO Capital in its Equity Capital Raise of INR 340 Crore from Marquee Institutional Investors BFSI FinTech April 13, 2023 Capital Markets Mergers and Acquisitions Private Equity
